Home - Products - Others - Other Targets - Competence-Stimulating Peptide-12261

Competence-Stimulating Peptide-12261

CAS No. 1235882-91-3

Competence-Stimulating Peptide-12261( —— )

Catalog No. M30330 CAS No. 1235882-91-3

Competence-Stimulating Peptide-12261, a sixteen peptide, is a fragment of competence-stimulating peptide.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Competence-Stimulating Peptide-12261
  • Note
    Research use only, not for human use.
  • Brief Description
    Competence-Stimulating Peptide-12261, a sixteen peptide, is a fragment of competence-stimulating peptide.
  • Description
    Competence-Stimulating Peptide-12261, a sixteen peptide, is a fragment of competence-stimulating peptide.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1235882-91-3
  • Formula Weight
    2153.45
  • Molecular Formula
    C100H149N31O23
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    Sequence:{Glu}{Ile}{Arg}{Gln}{Thr}{His}{Asn}{Ile}{Phe}{Phe}{Asn}{Phe}{Phe}{Lys}{Arg}{Arg}

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Jarosz LM, et al. Streptococcus mutans competence-stimulating peptide inhibits Candida albicans hypha formation. Eukaryot Cell. 2009 Nov;8(11):1658-64.
molnova catalog
related products
  • 3-(beta-D-Glucopyran...

    3-(β-D-Glucopyranosyloxy)-1,6-dihydroxy-2-methyl-9,10-anthracenedione, also known as an anthraquinone, has been specifically extracted from Rubia cordifolia.

  • Examorelin

    Examorelin is an agonist of growth hormone-releasing factor (GHRF), and for the treatment of cardiac diseases.hexarelin treatment protected cardiac function in the chronic phase as evidenced by higher ejection fraction and fractional shortening, as well as lower lung weight/body weight and lung weight/tibial length ratios, compared with vehicle treatment.?

  • Balanophonin

    Balanophonin shows potent α-glucosidase inhibitory activity, it has antioxidant, and anti-cancer activities. (±)-Balanophonin shows significant antibacterial activity against cariogenic oral streptococci, Streptococcus mutans and S. sobrinus.